两种微刺激方案促排卵结局以及抑制黄体生成素峰效果的自身对照研究OA
A self-controlled study on the ovulation induction outcomes and the luteinizing hormone peak inhibition effects of two mild ovary stimulation
目的 比较两种微刺激方案的促排卵结局以及抑制黄体生成素(luteinizing hormone,LH)峰的效果.方法 将同一批患者,采用两种微刺激方案进行促排卵,第一次促排卵采用枸橼酸氯米芬(clomifene citrate,CC)+人类绝经期促性腺激素(human menopausal gonadotropin,HMG)方案,此方案为对照组.第二次促排卵采用来曲唑(letrozole,LE)+HMG启动,当最大卵泡直径达14mm时,每天加用CC 50mg至扳机日,此方案为试验组(LE+HMG+CC组).结果 ①对照组和试验组比较,两组获卵数(3 vs 2,P=0.017),受精数(2 vs 1,P=0.033),卵裂数(2 vs 1,P=0.024)等指标差异有统计学意义.② 获卵率(68.10%vs72.34,P=0.396),减数分裂中期Ⅱ卵细胞(metaphase Ⅱ eggs,MⅡ)率(80.70%vs 87.80%,P=0.348),第 3 天胚胎(eggs on day 3,D3)优胚率(76.67%vs 87.50%,P=0.150),D3 可利用胚胎率(55.05%vs 67.61%,P=0.093)等指标,试验组有上升趋势,但差异没有统计学意义.试验组多原核(pronucleus,PN)率(9.6%vs 7.7%,P=0.652)有下降趋势,但差异没有统计学意义.结论 两种微刺激方案可得到相似的临床效果,患者可接受度好,可有效避免LH峰的发生,两种方案均值得在临床上进行推广.
Objective To compare the performance of two mild ovary stimulation(MOS)protocols in terms of ovulation induction outcomes and suppression of luteinizing hormone surges.Methods Ovulation induction was performed in the same cohort of patients using two different MOS protocols.The first ovulation induction cycle was conducted with the clomiphene citrate(CC)+human menopausal gonadotropin(HMG)protocol,which served as the control group.For the second ovulation induction cycle,the letrozole(LE)+HMG regimen was implemented,and when follicles reached a maximum diameter of 14 mm,CC(50 mg)was administered daily until the trigger day(denoted the LE+HMG+CC group).Results The numbers of retrieved eggs(3 vs 2,P=0.017),fertilized eggs(2 vs 1,P=0.033),and number of cleavages(2 vs 1,P=0.024)were significantly different between the control and LE+HMG+CC groups.The egg retrieval rate(68.10%vs 72.34%,P=0.396),proportion of metaphase Ⅱ eggs(80.70%vs 87.80%,P=0.348),proportion of excellent embryos on day 3(76.67%vs 87.50%,P=0.150),and proportion of usable eggs on day 3(55.05%vs 67.61%,P=0.093)showed an upward trend in the LE+HMG+CC group,although there was no statistical differences between the two groups.The proportion of multi-pronuclei zygotes showed a non-significant downward trend in the LE+HMG+CC group(9.6%vs 7.7%,P=0.652).Conclusion Both MOS regimens achieve similar clinical effectiveness,with good patient acceptance,and both effectively inhibit luteinizing hormone surges,these two protocols are worthy of promotion in clinical practice.
洪岭;钱晨;徐奎;梁阿娟;唐传玲;赵美;阮井玲;杨万里;冯晓;郑锦霞
同济大学附属妇产科医院辅助生殖医学科,上海 201204同济大学附属妇产科医院辅助生殖医学科,上海 201204山东第二医科大学附属医院生殖医学中心,山东潍坊 261033同济大学附属妇产科医院辅助生殖医学科,上海 201204同济大学附属妇产科医院辅助生殖医学科,上海 201204同济大学附属妇产科医院辅助生殖医学科,上海 201204同济大学附属妇产科医院辅助生殖医学科,上海 201204同济大学附属妇产科医院辅助生殖医学科,上海 201204上海中医药大学附属岳阳中西医结合医院妇科,上海 200437同济大学附属妇产科医院辅助生殖医学科,上海 201204
医药卫生
微刺激氯米芬来曲唑黄体生成素峰
mild ovary stimulationclomiphene citrateletrozoleluteinizing hormone surge
《同济大学学报(医学版)》 2026 (2)
224-228,5
上海市浦东新区科技发展基金事业单位民生科研专项项目(PKJ2023-Y58)上海市"科技创新行动计划"自然科学基金项目(23ZR1450300)
评论